NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
09/05/2023
Back to search
Official data from USPTO
AVAGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AVAGEN
ST13
US500000088580759Class
5, 42, 44
Filing
88580759
Registration
6493963
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
09/05/2023
Trademark type
Word
Nice classes
5, 42, 44
Filing date
08/15/2019
Registration date
09/21/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/21/2021
Last transaction
06/17/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2021-05-00
First use in commerce
2021-05-00
Drawing code
4
Owner type
03
Owner location
Menlo Park, CA, US
Examiner
JAGANNATHAN, SIDDHARTH
Law office
M50
Current location
TMO LAW OFFICE 114
Holders and representatives
Holders
Avellino Lab USA, Inc.
Representatives
Andrew J. Gray IV MORGAN, LEWIS & BOCKIUS LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic test kits comprised of medical diagnostic reagents and assays * for diagnosing and treating genetic disorders and for eyecare *
Class 42
Electronic data storagestorage of genetic data and scientific analysis services performed thereto * relating to diagnoses and treatment of genetic disorders and for eyecare *
Class 44
DNA screening for medical diagnostic purposes * relating to genetic disorders and for eyecare * ; medical information servicesproviding risk scores and treatment and diagnostic information associated with genesvariantsmutations associated with eye disease
Publications
History of USPTO decisions and trademark events.
31 publications found
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
08/03/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/25/2023
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
12/13/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/06/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
07/21/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/21/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/17/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/14/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/09/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/09/2021
IUAF
USE AMENDMENT FILED
07/29/2021
EISU
TEAS STATEMENT OF USE RECEIVED
07/29/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/05/2021
EX1G
SOU EXTENSION 1 GRANTED
02/03/2021
EXT1
SOU EXTENSION 1 FILED
02/03/2021
EEXT
SOU TEAS EXTENSION RECEIVED
02/03/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/18/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/23/2020
PUBO
PUBLISHED FOR OPPOSITION
06/23/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/18/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/16/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/15/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/15/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/15/2019
GNRT
NON-FINAL ACTION E-MAILED
11/15/2019
CNRT
NON-FINAL ACTION WRITTEN
11/15/2019
DOCK
ASSIGNED TO EXAMINER
11/14/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/31/2019
NWAP
NEW APPLICATION ENTERED
08/19/2019
Continuous trademark protection
Get notified about every new filing that threatens AVAGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.